Evidence map›Paper›PMID 21653728›Full record

ArticleJournal of neurophysiology2011

Polysynaptic excitatory postsynaptic potentials that trigger spasms after spinal cord injury in rats are inhibited by 5-HT1B and 5-HT1F receptors.

Katherine C Murray, Marilee J Stephens, Michelle Rank, Jessica D'Amico, Monica A Gorassini, David J Bennett

Registry-linked trialOpen access · greenAbstract readComparative Study
In one paragraph

Article in Journal of neurophysiology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01587170 (Phase 2), which is not on this map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01587170 completednot on this mapstarted 2012, after this paper: background citation

Phase 2: Effects of Zolmitriptan on Sensory Afferent Transmission After Spinal Cord Injury

TypeobservationalSponsorUniversity of AlbertaRan2012 to 2012Enrolled13ConditionsSpinal Cord Injuries, Muscle Spasticity
3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 62 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Loss of 5-HTFrontiers in neural circuits · 2025
    Article
  6. Muscle Spasms after Spinal Cord Injury Stem from Changes in Motoneuron Excitability and Synaptic Inhibition, Not Synaptic Excitation.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2024
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. 5-HTThe European journal of neuroscience · 2022
    Article
  12. Review
  13. FDA-approved 5-HTExperimental neurology · 2021
    Article
  14. Article
  15. The Involvement of CaFrontiers in neural circuits · 2021
    Article
  16. Article
  17. Article
  18. Article
  19. 5-HTJournal of neurophysiology · 2019
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Katherine C MurrayCentre for Neuroscience, University of Alberta, Edmonton, Alberta, Canada.
Marilee J Stephens
Michelle Rank
Jessica D'Amico
Monica A Gorassini
David J Bennett
University of Alberta · CA

Funding

Motoneuron Properties in Chronic Spinal InjuryR01NS047567 · NINDS · UNIVERSITY OF ALBERTA · PI BENNETT, DAVID JAMES, FOUAD, KARIM · 2004 to 2020
$4.0M
Recovery of motoneuron excitability after spinal injuryR01NS048170 · NINDS · UNIVERSITY OF ALBERTA · PI GORASSINI, MONICA A · 2006 to 2010
$1.0M
Canadian Institutes of Health ResearchNINDS NIH HHS NS-047567NINDS NIH HHS NS-048170
6 · The paper itself

Abstract

Sensory afferent transmission and associated spinal reflexes are normally inhibited by serotonin (5-HT) derived from the brain stem. Spinal cord injury (SCI) that eliminates this 5-HT innervation leads to a disinhibition of sensory transmission and a consequent emergence of unusually long polysynaptic excitatory postsynaptic potentials (EPSPs) in motoneurons. These EPSPs play a critical role in triggering long polysynaptic reflexes (LPRs) that initiate muscles spasms. In the present study we examined which 5-HT receptors modulate the EPSPs and whether these receptors adapt to a loss of 5-HT after chronic spinal transection in rats. The EPSPs and associated LPRs recorded in vitro in spinal cords from chronic spinal rats were consistently inhibited by 5-HT(1B) or 5-HT(1F) receptor agonists, including zolmitriptan (5-HT(1B/1D/1F)) and LY344864 (5-HT(1F)), with a sigmoidal dose-response relation, from which we computed the 50% inhibition (EC(50)) and potency (-log EC(50)). The potencies of 5-HT receptor agonists were highly correlated with their binding affinity to 5-HT(1B) and 5-HT(1F) receptors, and not to other 5-HT receptors. Zolmitriptan also inhibited the LPRs and general muscle spasms recorded in vivo in the awake chronic spinal rat. The 5-HT(1B) receptor antagonists SB216641 and GR127935 and the inverse agonist SB224289 reduced the inhibition of LPRs by 5-HT(1B) agonists (zolmitriptan). However, when applied alone, SB224289, SB216641, and GR127935 had no effect on the LPRs, indicating that 5-HT(1B) receptors do not adapt to chronic injury, remaining silent, without constitutive activity. The reduction in EPSPs with zolmitriptan unmasked a large glycine-mediated inhibitory postsynaptic current (IPSC) after SCI. This IPSC and associated chloride current reversed at -73 mV, slightly below the resting membrane potential. Zolmitriptan did not change motoneuron properties. Our results demonstrate that 5-HT(1B/1F) agonists, such as zolmitriptan, can restore inhibition of sensory transmission after SCI without affecting general motoneuron function and thus may serve as a novel class of antispastic drugs.

Indexed as

AnimalsElectric StimulationExcitatory Postsynaptic PotentialsFemaleNeural InhibitionRatsReceptor, Serotonin, 5-HT1BReceptor, Serotonin, 5-HT1FReceptors, SerotoninSacrumSerotonin 5-HT1 Receptor AgonistsSpasmSpinal Cord InjuriesReceptor, Serotonin, 5-HT1BReceptor, Serotonin, 5-HT1FReceptors, SerotoninSerotonin 5-HT1 Receptor Agonists

Identifiers

PMID21653728
PMCPMC3154834
OpenAlexW1996846624

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.